"COVID-19's Impact on Dopamine Neurons"

A study reveals that SARS-CoV-2 can infect dopamine neurons, leading to senescence and inflammation, potentially contributing to long COVID symptoms like brain fog and depression. Approximately 5% of dopamine neurons can be infected, and three drugs have been identified as potential protectors against SARS-CoV-2 infection in these neurons. The findings suggest the need for careful, long-term monitoring of neurological problems in COVID-19 patients and may shed light on the risk of developing Parkinson's-related symptoms.